The differential effect of risperidone and olanzapine on insulin sensitivity after 3 weeks of treatment: a HOMA pilot study

Pharmacopsychiatry. 2012 May;45(3):96-9. doi: 10.1055/s-0031-1297935. Epub 2011 Dec 15.

Abstract

Background and methods: Patients with an acute psychotic episode underwent HOMA testing for insulin sensitivity (IS) prior to and after 3 weeks of treatment with olanzapine (n = 7) or risperidone (n = 7).

Results and discussion: The HOMA-IS index was reduced in the olanzapine group, but significantly increased in patients treated with risperidone. There was a significant "time × medication" interaction (p = 0.03). The BMI significantly increased as a result of both treatments. IS can be acutely ameliorated by antipsychotic treatment with risperidone despite weight increase.

Conclusions: Compared to risperidone, the IS is impaired after a 3-week treatment with olanzapine. Already short-term antipsychotic treatment may have eff ects on insulin sensitivity.

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antipsychotic Agents / administration & dosage*
  • Antipsychotic Agents / adverse effects
  • Benzodiazepines / administration & dosage*
  • Benzodiazepines / adverse effects
  • Body Mass Index
  • Female
  • Homeostasis / drug effects
  • Homeostasis / physiology
  • Humans
  • Insulin Resistance / physiology*
  • Male
  • Metabolic Diseases / chemically induced*
  • Metabolic Diseases / physiopathology
  • Middle Aged
  • Olanzapine
  • Pilot Projects
  • Prospective Studies
  • Risperidone / administration & dosage
  • Risperidone / adverse effects*
  • Schizophrenia / drug therapy*
  • Young Adult

Substances

  • Antipsychotic Agents
  • Benzodiazepines
  • Risperidone
  • Olanzapine